Cited by

• Cardiostimulatory effects of prenalterol, a beta-1 adrenoceptor partial agonist, in vivo and in vitro. Correlation between physiological effects and adenylate cyclase activity.

  Hedberg A, Carlsson E, Fellenius E, Lundgren B. Hedberg A, et al. Naunyn Schmiedebergs Arch Pharmacol. 1982 Feb;318(3):185-91. doi: 10.1007/BF00500479. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6121296
• Role of beta-adrenoceptor-adenylate cyclase system in the developmental decrease in sensitivity to isoprenaline in foetal and neonatal rat heart.

  Tanaka H, Shigenobu K. Tanaka H, et al. Br J Pharmacol. 1990 May;100(1):138-42. doi: 10.1111/j.1476-5381.1990.tb12065.x. Br J Pharmacol. 1990. PMID: 2164856 Free PMC article.
• Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion.

  McMartin L, Summers RJ. McMartin L, et al. Br J Pharmacol. 1999 Jun;127(4):1012-20. doi: 10.1038/sj.bjp.0702618. Br J Pharmacol. 1999. PMID: 10433510 Free PMC article.
• Competitive and non-competitive interactions between specific ligands and beta-adrenoceptors in living cardiac cells.

  Porzig H, Becker C, Reuter H. Porzig H, et al. Naunyn Schmiedebergs Arch Pharmacol. 1982 Nov;321(2):89-99. doi: 10.1007/BF00518474. Naunyn Schmiedebergs Arch Pharmacol. 1982. PMID: 6296703
• On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.

  Lemoine H, Teng KJ, Slee SJ, Kaumann AJ. Lemoine H, et al. Naunyn Schmiedebergs Arch Pharmacol. 1989 Jan-Feb;339(1-2):113-28. doi: 10.1007/BF00165133. Naunyn Schmiedebergs Arch Pharmacol. 1989. PMID: 2566921